INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (156109,26191,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156127,26192,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156129,26192,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156131,26192,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156149,26427,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156151,26427,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156153,26427,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156171,26428,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156173,26428,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156175,26428,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156193,26933,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156195,26933,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156197,26933,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156215,26934,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156217,26934,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156219,26934,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156237,26936,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156239,26936,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156241,26936,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156259,27808,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156261,27808,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156263,27808,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156281,27809,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156283,27809,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156285,27809,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (156303,27810,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156305,27810,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156307,27810,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156325,27811,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156327,27811,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'789ccd564b72dc3610bd4a2f67aaa4b17eb6a7b253a294a285655734ce1e247b4844244003e0c8dce50eb9470e91a3e424790d901c6a2455594916d971068deed7af5f77e3eae3dde5f58f74797b4597571f6e6e6fee363f5f6e6e3eded2a662bad3a6ac993e7bc6e9d5f12fca0455f29f7fd04eabda93724c5beb489be0d48e8ded3c75b0b5a6ee577463b69c076d8d27bba500778e7dab9d0ad6f5841b7920650af2761b2868ef3bf62bfaa48266133c3db02e2bc4a78b13ba2f69b15e539df925215e631d7f47676f4fa82929587a7b12bf78c770fc8e2adbb9673dd5ec3d802873e0537c253f70f3e6be7c53a81e49117fe9545df754e89d2eb8a0c27a46d681de1d8bf9fa388692f4d9ed40c8733997ca0767c5c4076d541d532ed9e880abf863a4c2d3429bbcee0a011a2a44a25c81cc82b29e6e19f4b0d38a4a6bac739565c58270cb8d4256cbd7f0f6efd9fa2f788ae404c72a34082b6ce595b346e7f4889648d78c3d3d117c445b87c072398321d8b1b52d753e509cd7daa41f6deb94f672d793e11c59c1fb8aeec05ccd6e001bf34cb43bce6d03509289caec8ec9037e5d90b108c5a2f062453f81a5e9f660301cc69ef0a1cb32eb8cf0ee856b9e618f044c16f39cc08a536d4f0d98cd04cb974ebbd1a5b8411e0fccf7e2228c565356c2766e0da8ea78c68029dee0fa214b5b5bd7f6e1b86b1f396f70bd42f1b6b0a5e856900d6a16682bfaec38544ea365a5f8518054202082dfaee60a5dd165d1d5d0d45fbffd4e9b073bb0055fa306555e894e9499c421a76b71757a364a7333a96462a5c53f60456f67b92309fe1a52dd703052f782d86cd3d6a061ead50136034137e57744be13849e5a677d80b5242df2e25617bae89b6485d3da9a520433c8d5780de18cd5c4a599aa56f4831a7898a2d2830e088478be8518e0a975ba91b4c0ee5000dfb795aef524b70a33970ae5eeb79af193bfaa063d9232ca18458d5a6634a58c9431fbc807a44f56d061c80894874a040ae900a40e18f3fb60126f047594e48156c7349a8424cd39ef814615692f280220dd748da0dfca0848ea5ac5e592c42076529d56a0c6e1b76f87b1de25b83432075947cc621f774ed3f9bcab95a38325e46c17447d98290a6511395911b76a5a9debba8eb2ed27acc8dec4396141ba929bdfa75ec1950f18d5a68c751fc41ca70bb8291c6e89b24f310f11e1ece49bc6629abbe772e36254f8e289c4c15bd051e35118f3e40aa7db495911ccd0f173db89196d7e1d87cef280f6248057d03d0018c99e620c74dfb285fce07cb15f1dd294424324680db5f651f72dba09b652929297744c57d6e36b26a24cc92485f0af39369e35c93866fc697e9d549e5b97f6a6a58dcaf06239a7d5f435b84641fe3940a1eb594d089a3b6e83ceb9c17a3e04bb88b37a79007821519623b0e7b19c5fbc70f09e4e5f23b4718cbe1ca614edc5321f9cad6376fb7ba0e7f4db56ff41e847115e4cecb5eed783f719fdafe950bc008272e1697fa942a6165e6d69f3c5411680190f398076cc4924f3ce4b4e9e8ea5d818cf76fcffaa5716f199b39c6f5ac4951d311b0efb70fb79f364c85fc4d5fd7e2c7cc6bd0584b87d7523fb508534edd36b13065838f256f47dd306dbe0ef3cf220e536398bcf6cea3b8cbc62d8d9587ee21ef5b55950dac856bd9c23393d4904eeb7fee3259cb09b7e9fe2ecbd7d8dc2b5f0977150c71537b6ee05183401add9dce6b9963c2bae5b595c3b712f69e1a0736e04ae72a93eb67b97f2da8a1024bb7450d648dd757838709b9e1babbf01c61cd8fc','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156329,27811,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156347,27812,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156349,27812,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156351,27812,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156369,28680,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156371,28680,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156373,28680,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156391,28681,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156393,28681,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156395,28681,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156413,28682,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156415,28682,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156417,28682,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156435,28708,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'789ccd595d52234712be4abe4c048a603480191bcf3e31806789180b0289d8e75277a955a6bbaba7aa5a8cde7c073fed2df60c7b149f64bfccaa6eb584d801af23d62f044855f9f3e5977fc5e5cdf4fcd3159d4f2ee9fcf2e7ebc9f57476773ebbbe99d06c693c99da6b1708bf2dac2345b74be52a95ade9635b3ed0adca1e54a149d539c9e1a0eb5ce772b671ba51ced4057fecd44ad7b6f5a4f2ca7c0dadd39e6c5daec774693d4b703ab35585db2a185b476d72af6a7dd696ca113ec80d8e852d79a6fe051fe10a29a7d32dfcac448c2aa9695d637dafedba5ec4e3f8604161c98a7d639c0ad6ad0962219e9df176112818ef5bedc77033185d074f8fda144b76e9f4881e0a3a383ba372ee476c5b659dfe4027ef8fa82a28587a7f24bfe99586e0ef69695bb75752a9bd8721aade91c9b2a21c8879f750bccbd51abe91fed2aab25c038b9561a873f14e05fafe2d1f3f7b2baa24146ea54abfcfe742f9e02c1ff1c1304aec72a16b1370151f7450783a307556b6391b1a96d044996a3db4ced734d180473ba3a8b0b5756e69b5d26ce142570a5e8d5e83dbff8ed69f819380139c56014c0c8c56b674b636196dc112e9be41cff4001fd2c241315f9ee320d0b1a52d4c9620ce4a53c73f9ac629e3f9aea75a67f00ad2c7340572a576c958f133c2dea7073c5173bbd2e4617e99536da14a1307654c7f074afded74207d29a9e1433b9f5b5733ee9eb1d603db0580fec4d027a0e254b3a60ac8ced9962f2d1231896431f0e351eb071611ba53bd578c76666b40d5ea010275fe0ed777515ad8b2b48f6fdb664b7885eb4b046f81b3246225e3239bd9b431dd3b1d96ce04a9422404a41c0aa17c321e32744ce7795b8253bffffa1bcd1e6d420bb23a0eaa6cc93c51754f0efef68c451d9f74d49cf52ce95169f00950318b81ef70427f4d45115f74d03d43365b352560e8733599ad6141dbfb7748be650b3d2aacf501a7d969a6976e4c6ef275154fe1dbd2d6051326d1b5f606c4e9a2894b03568de942251c7aadf4680214419f6f4006486a9ca9d82da09b02e0d7cdd294a6a7db12859972e51e1646e34ffd5555c891e8d15c23a8c2658da4e492d2792f7880fa64d93a141936e571c904057560a4090a18f5ca585f67d461a407521dd5a8271227e730072a95ebd4c26090a9da8aad5f700988ec4248118f48063ec7d169d8d43cb6b0be86a67817c0b2e63aa88dd8cce79f34ac61a772b60dcc3ed41485b0309d2c935b558dc94c590a6dd7bdadf0be963a6101bae29b1f63aee0cacf28d57521714f6496ea026c72875bccec63d4436838397a51598c75f73bbe71da31fce009c5815b30c27121c6d0b9dc99a667961893327e78b647a66fda7e3cda813d12e0157027039e8c0b09ee89c6180032d0c1a6757052320c02d019d8ba16de634e0838cb2129f448504cc3c9864673c5b514d4ffa425f564c6e826a0dba1005259665dec9c96666a5e6a3aa671f7db874e3662f2c76d64c4f6d282cd99ea26984c57e8d0bbd61e48b91eed587cc05a469d61fb6df9eef4992f7ea0e3d770adaba4cfab29987e12697cb7fbf7f0ec9978bb9103b88e5f360dec98b2abf1d968bc4afc59923e08c76b921643415098c09fa41c4fd2b5c120179ba1d4b6009b31dbc168a77524cd3019a390a7954a72656f11f88ba5cf81cc3ea361fb85666e1c838ab151b729424f2affa9f4f31fbad0cff5dac20469c9a6e226a9426c017104c50174211e20fdba6a82e5fd22132438e075a659e6bccf44d4c13c35727444168f08db7950a6e6567b3eb4e4f82842b81905b63b73b4bd5e6f5c1c0ce19f10ba06f2e63aa8b74b5dd972cd868115609bcd6c9619f673a9cb86bbd98ac5b35bf8a275ae335c651c7fb4fc36fab5602ab077f18ba284ebaec534a19b3883606dbbbebbba9035f1a79b3bba9f5ed14f387fbecd4918783d602c169156e606e6c61d3cac314007d60088e26ec75e694c8074e041e04bf9acdf076fd10b61d7bd17a3f76fa2239e51b87d63b033651b9840718ca9b7b2c75bfed2d6983c7ebebdb99b9d4f661fe2c69b01461921c0d039a68db01eae949cedb5a547c97b89711cd41135e468473c9017f80b691bde1890f76c11a286b34626b7bcc522f1a841dd38d6a679032b73d4c3341cd3276b79eab20b645f5a683b79be2d0a1972443bcf8eb68dfbc166c5dea442572d340fee8afde79559340fb52a99ad16282206c64bed49186033c88decd1c389c5dbdc80c630a09bd5795ed37562800ce32b8588c8aafe147edfa32800e4aee570019492b79e4dcd393e7a43ecf78a4d49a91974053aa8e829f6a0942a7d0e37bc58e49ee31838ebeeacad68b6b9440727effffd2fba40c7035338332eb66ddf387f9b444d39bf11d47f489f606dd7fdfbc3fdf496908bdcbca47c579ffbd27f34fef10d4d235417cbd23ad48c97dd7cff862eb140384663fbc2716a15e9c2715c679f3f1f159ca4e3277be4730d3e1a9fe2a389ba285f74fd33622203e11df24cbbdf7ffda77f995f777ae14cc181c0e583d33f390cbdbad3bef9be28703d9a7d5f7841e47a6527a7af0df7c9133b5f0d68aff49b91ff2f4c7941e48f77aedfd41877e2dbc426974b2e303b0f14c3f787dda1dd740d817bd0a6a8c457bc64c3211b1197b39dd292142cb8fd73893771a576b25df17268b083e669afe3c2b2755f9c8ee7434460053f2addbd91f5b60d6be82fad38e8ed6640089627161ef876bc307ebbe8a6edb72f73a5cc8826f8ad4623df7788f2df006ffc471aa1f4b2fd5f15a5425d9ddb10ca3823612cf17baa3a3f56ac5429338330a0c0cce8b7dd94271f68cab537459de2cc7d2eb9d27416e0ef6fbe0803707c8919912765d4f76c599b2fadc85254ca4b029297c78325fae298d40813474e3f9e1288f98d148f3c80168cdeaca5c758da4d4221ee30ec5874758049df7d18f9eaf361f7e6ed639b8f597233b98ae90172386e37831e35a6792c71a0dba275b2c526daf6d72042edd0941fa6d293b2e460d28fd68c0129cec5f254d69a68c8a26c0da0616e606ec0accacfdeffcfc1e6af37d46423c0b39f69accced239bbc825286a4e5c9616342a36b1d621be3ff30e0479a3ea2196e33e5b22589e09b68f944dadca060d5f2add7e16ff4b834fcc6c78fa19e2a58deb28b8353a94a316ff9857cdc1503c85e738ac592566b9d43ba91f968fb11994b8f3caec832c17b23d78631e5c829319d29b83e94d0e257e336ca64d789d56348b1bde7d8c8fd5508dba73c5d27a7d24bd1301bec6207bf4464c1b734151ce80351987a7bbb151e768f94b694cd47fe8514670c1cb1cf1bd7c3b9456ad9cbb0dc18d9532457fb403e5af7c0ff82529be7d9bd25eb1667f855997b067781247bc86a14e3f4dcba323ebe2bc8ffd3940357b1af077e210c1c220e31e0cb2c668c48f57ef9d97e1d3894e744d9eafabad73d0cf04eeab8aa00cf315d9cdff356f7812637339addd0c72bac7ad3dbabc9f4ea92cea75835ef27d7b3f17f003c3d1b66','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156437,28708,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'789ccd564b72dc3610bd4a2f67aaa4b17eb6a7b253a294a285655734ce1e247b4844244003e0c8dce50eb9470e91a3e424790d901c6a2455594916d971068deed7af5f77e3eae3dde5f58f74797b4597571f6e6e6fee363f5f6e6e3eded2a662bad3a6ac993e7bc6e9d5f12fca0455f29f7fd04eabda93724c5beb489be0d48e8ded3c75b0b5a6ee577463b69c076d8d27bba500778e7dab9d0ad6f5841b7920650af2761b2868ef3bf62bfaa48266133c3db02e2bc4a78b13ba2f69b15e539df925215e631d7f47676f4fa82929587a7b12bf78c770fc8e2adbb9673dd5ec3d802873e0537c253f70f3e6be7c53a81e49117fe9545df754e89d2eb8a0c27a46d681de1d8bf9fa388692f4d9ed40c8733997ca0767c5c4076d541d532ed9e880abf863a4c2d3429bbcee0a011a2a44a25c81cc82b29e6e19f4b0d38a4a6bac739565c58270cb8d4256cbd7f0f6efd9fa2f788ae404c72a34082b6ce595b346e7f4889648d78c3d3d117c445b87c072398321d8b1b52d753e509cd7daa41f6deb94f672d793e11c59c1fb8aeec05ccd6e001bf34cb43bce6d03509289caec8ec9037e5d90b108c5a2f062453f81a5e9f660301cc69ef0a1cb32eb8cf0ee856b9e618f044c16f39cc08a536d4f0d98cd04cb974ebbd1a5b8411e0fccf7e2228c565356c2766e0da8ea78c68029dee0fa214b5b5bd7f6e1b86b1f396f70bd42f1b6b0a5e856900d6a16682bfaec38544ea365a5f8518054202082dfaee60a5dd165d1d5d0d45fbffd4e9b073bb0055fa306555e894e9499c421a76b71757a364a7333a96462a5c53f60456f67b92309fe1a52dd703052f782d86cd3d6a061ead50136034137e57744be13849e5a677d80b5242df2e25617bae89b6485d3da9a520433c8d5780de18cd5c4a599aa56f4831a7898a2d2830e088478be8518e0a975ba91b4c0ee5000dfb795aef524b70a33970ae5eeb79af193bfaa063d9232ca18458d5a6634a58c9431fbc807a44f56d061c80894874a040ae900a40e18f3fb60126f047594e48156c7349a8424cd39ef814615692f280220dd748da0dfca0848ea5ac5e592c42076529d56a0c6e1b76f87b1de25b83432075947cc621f774ed3f9bcab95a38325e46c17447d98290a6511395911b76a5a9debba8eb2ed27acc8dec4396141ba929bdfa75ec1950f18d5a68c751fc41ca70bb8291c6e89b24f310f11e1ece49bc6629abbe772e36254f8e289c4c15bd051e35118f3e40aa7db495911ccd0f173db89196d7e1d87cef280f6248057d03d0018c99e620c74dfb285fce07cb15f1dd294424324680db5f651f72dba09b652929297744c57d6e36b26a24cc92485f0af39369e35c93866fc697e9d549e5b97f6a6a58dcaf06239a7d5f435b84641fe3940a1eb594d089a3b6e83ceb9c17a3e04bb88b37a79007821519623b0e7b19c5fbc70f09e4e5f23b4718cbe1ca614edc5321f9cad6376fb7ba0e7f4db56ff41e847115e4cecb5eed783f719fdafe950bc008272e1697fa942a6165e6d69f3c5411680190f398076cc4924f3ce4b4e9e8ea5d818cf76fcffaa5716f199b39c6f5ac4951d311b0efb70fb79f364c85fc4d5fd7e2c7cc6bd0584b87d7523fb508534edd36b13065838f256f47dd306dbe0ef3cf220e536398bcf6cea3b8cbc62d8d9587ee21ef5b55950dac856bd9c23393d4904eeb7fee3259cb09b7e9fe2ecbd7d8dc2b5f0977150c71537b6ee05183401add9dce6b9963c2bae5b595c3b712f69e1a0736e04ae72a93eb67b97f2da8a1024bb7450d648dd757838709b9e1babbf01c61cd8fc','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156439,28708,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156457,28711,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156459,28711,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156461,28711,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156479,28712,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL);
INSERT OR REPLACE INTO dosage_guidelines (id,med_id,dailymed_setid,min_dose,max_dose,frequency,duration,instructions,condition,source,is_pediatric,dose_unit,route,dosage_form,patient_category,is_geriatric,is_pregnant,renal_adjustment,hepatic_adjustment,warnings,contraindications,adverse_reactions,black_box_warning,overdose_management,max_daily_dose,loading_dose,maintenance_dose,special_populations,pregnancy_category,lactation_info) VALUES (156481,28712,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156483,28712,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156501,28713,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'789ccd595d52234712be4abe4c048a603480191bcf3e31806789180b0289d8e75277a955a6bbaba7aa5a8cde7c073fed2df60c7b149f64bfccaa6eb584d801af23d62f044855f9f3e5977fc5e5cdf4fcd3159d4f2ee9fcf2e7ebc9f57476773ebbbe99d06c693c99da6b1708bf2dac2345b74be52a95ade9635b3ed0adca1e54a149d539c9e1a0eb5ce772b671ba51ced4057fecd44ad7b6f5a4f2ca7c0dadd39e6c5daec774693d4b703ab35585db2a185b476d72af6a7dd696ca113ec80d8e852d79a6fe051fe10a29a7d32dfcac448c2aa9695d637dafedba5ec4e3f8604161c98a7d639c0ad6ad0962219e9df176112818ef5bedc77033185d074f8fda144b76e9f4881e0a3a383ba372ee476c5b659dfe4027ef8fa82a28587a7f24bfe99586e0ef69695bb75752a9bd8721aade91c9b2a21c8879f750bccbd51abe91fed2aab25c038b9561a873f14e05fafe2d1f3f7b2baa24146ea54abfcfe742f9e02c1ff1c1304aec72a16b1370151f7450783a307556b6391b1a96d044996a3db4ced734d180473ba3a8b0b5756e69b5d26ce142570a5e8d5e83dbff8ed69f819380139c56014c0c8c56b674b636196dc112e9be41cff4001fd2c241315f9ee320d0b1a52d4c9620ce4a53c73f9ac629e3f9aea75a67f00ad2c7340572a576c958f133c2dea7073c5173bbd2e4617e99536da14a1307654c7f074afded74207d29a9e1433b9f5b5733ee9eb1d603db0580fec4d027a0e254b3a60ac8ced9962f2d1231896431f0e351eb071611ba53bd578c76666b40d5ea010275fe0ed777515ad8b2b48f6fdb664b7885eb4b046f81b3246225e3239bd9b431dd3b1d96ce04a9422404a41c0aa17c321e32744ce7795b8253bffffa1bcd1e6d420bb23a0eaa6cc93c51754f0efef68c451d9f74d49cf52ce95169f00950318b81ef70427f4d45115f74d03d43365b352560e8733599ad6141dbfb7748be650b3d2aacf501a7d969a6976e4c6ef275154fe1dbd2d6051326d1b5f606c4e9a2894b03568de942251c7aadf4680214419f6f4006486a9ca9d82da09b02e0d7cdd294a6a7db12859972e51e1646e34ffd5555c891e8d15c23a8c2658da4e492d2792f7880fa64d93a141936e571c904057560a4090a18f5ca585f67d461a407521dd5a8271227e730072a95ebd4c26090a9da8aad5f700988ec4248118f48063ec7d169d8d43cb6b0be86a67817c0b2e63aa88dd8cce79f34ac61a772b60dcc3ed41485b0309d2c935b558dc94c590a6dd7bdadf0be963a6101bae29b1f63aee0cacf28d57521714f6496ea026c72875bccec63d4436838397a51598c75f73bbe71da31fce009c5815b30c27121c6d0b9dc99a667961893327e78b647a66fda7e3cda813d12e0157027039e8c0b09ee89c6180032d0c1a6757052320c02d019d8ba16de634e0838cb2129f448504cc3c9864673c5b514d4ffa425f564c6e826a0dba1005259665dec9c96666a5e6a3aa671f7db874e3662f2c76d64c4f6d282cd99ea26984c57e8d0bbd61e48b91eed587cc05a469d61fb6df9eef4992f7ea0e3d770adaba4cfab29987e12697cb7fbf7f0ec9978bb9103b88e5f360dec98b2abf1d968bc4afc59923e08c76b921643415098c09fa41c4fd2b5c120179ba1d4b6009b31dbc168a77524cd3019a390a7954a72656f11f88ba5cf81cc3ea361fb85666e1c838ab151b729424f2affa9f4f31fbad0cff5dac20469c9a6e226a9426c017104c50174211e20fdba6a82e5fd22132438e075a659e6bccf44d4c13c35727444168f08db7950a6e6567b3eb4e4f82842b81905b63b73b4bd5e6f5c1c0ce19f10ba06f2e63aa8b74b5dd972cd868115609bcd6c9619f673a9cb86bbd98ac5b35bf8a275ae335c651c7fb4fc36fab5602ab077f18ba284ebaec534a19b3883606dbbbebbba9035f1a79b3bba9f5ed14f387fbecd4918783d602c169156e606e6c61d3cac314007d60088e26ec75e694c8074e041e04bf9acdf076fd10b61d7bd17a3f76fa2239e51b87d63b033651b9840718ca9b7b2c75bfed2d6983c7ebebdb99b9d4f661fe2c69b01461921c0d039a68db01eae949cedb5a547c97b89711cd41135e468473c9017f80b691bde1890f76c11a286b34626b7bcc522f1a841dd38d6a679032b73d4c3341cd3276b79eab20b645f5a683b79be2d0a1972443bcf8eb68dfbc166c5dea442572d340fee8afde79559340fb52a99ad16282206c64bed49186033c88decd1c389c5dbdc80c630a09bd5795ed37562800ce32b8588c8aafe147edfa32800e4aee570019492b79e4dcd393e7a43ecf78a4d49a91974053aa8e829f6a0942a7d0e37bc58e49ee31838ebeeacad68b6b9440727effffd2fba40c7035338332eb66ddf387f9b444d39bf11d47f489f606dd7fdfbc3fdf496908bdcbca47c579ffbd27f34fef10d4d235417cbd23ad48c97dd7cff862eb140384663fbc2716a15e9c2715c679f3f1f159ca4e3277be4730d3e1a9fe2a389ba285f74fd33622203e11df24cbbdf7ffda77f995f777ae14cc181c0e583d33f390cbdbad3bef9be28703d9a7d5f7841e47a6527a7af0df7c9133b5f0d68aff49b91ff2f4c7941e48f77aedfd41877e2dbc426974b2e303b0f14c3f787dda1dd740d817bd0a6a8c457bc64c3211b1197b39dd292142cb8fd73893771a576b25df17268b083e669afe3c2b2755f9c8ee7434460053f2addbd91f5b60d6be82fad38e8ed6640089627161ef876bc307ebbe8a6edb72f73a5cc8826f8ad4623df7788f2df006ffc471aa1f4b2fd5f15a5425d9ddb10ca3823612cf17baa3a3f56ac5429338330a0c0cce8b7dd94271f68cab537459de2cc7d2eb9d27416e0ef6fbe0803707c8919912765d4f76c599b2fadc85254ca4b029297c78325fae298d40813474e3f9e1288f98d148f3c80168cdeaca5c758da4d4221ee30ec5874758049df7d18f9eaf361f7e6ed639b8f597233b98ae90172386e37831e35a6792c71a0dba275b2c526daf6d72042edd0941fa6d293b2e460d28fd68c0129cec5f254d69a68c8a26c0da0616e606ec0accacfdeffcfc1e6af37d46423c0b39f69accced239bbc825286a4e5c9616342a36b1d621be3ff30e0479a3ea2196e33e5b22589e09b68f944dadca060d5f2add7e16ff4b834fcc6c78fa19e2a58deb28b8353a94a316ff9857cdc1503c85e738ac592566b9d43ba91f968fb11994b8f3caec832c17b23d78631e5c829319d29b83e94d0e257e336ca64d789d56348b1bde7d8c8fd5508dba73c5d27a7d24bd1301bec6207bf4464c1b734151ce80351987a7bbb151e768f94b694cd47fe8514670c1cb1cf1bd7c3b9456ad9cbb0dc18d9532457fb403e5af7c0ff82529be7d9bd25eb1667f855997b067781247bc86a14e3f4dcba323ebe2bc8ffd3940357b1af077e210c1c220e31e0cb2c668c48f57ef9d97e1d3894e744d9eafabad73d0cf04eeab8aa00cf315d9cdff356f7812637339addd0c72bac7ad3dbabc9f4ea92cea75835ef27d7b3f17f003c3d1b66','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156503,28713,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156505,28713,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156523,28723,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156525,28723,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'789ccd564b72dc3610bd4a2f67aaa4b17eb6a7b253a294a285655734ce1e247b4844244003e0c8dce50eb9470e91a3e424790d901c6a2455594916d971068deed7af5f77e3eae3dde5f58f74797b4597571f6e6e6fee363f5f6e6e3eded2a662bad3a6ac993e7bc6e9d5f12fca0455f29f7fd04eabda93724c5beb489be0d48e8ded3c75b0b5a6ee577463b69c076d8d27bba500778e7dab9d0ad6f5841b7920650af2761b2868ef3bf62bfaa48266133c3db02e2bc4a78b13ba2f69b15e539df925215e631d7f47676f4fa82929587a7b12bf78c770fc8e2adbb9673dd5ec3d802873e0537c253f70f3e6be7c53a81e49117fe9545df754e89d2eb8a0c27a46d681de1d8bf9fa388692f4d9ed40c8733997ca0767c5c4076d541d532ed9e880abf863a4c2d3429bbcee0a011a2a44a25c81cc82b29e6e19f4b0d38a4a6bac739565c58270cb8d4256cbd7f0f6efd9fa2f788ae404c72a34082b6ce595b346e7f4889648d78c3d3d117c445b87c072398321d8b1b52d753e509cd7daa41f6deb94f672d793e11c59c1fb8aeec05ccd6e001bf34cb43bce6d03509289caec8ec9037e5d90b108c5a2f062453f81a5e9f660301cc69ef0a1cb32eb8cf0ee856b9e618f044c16f39cc08a536d4f0d98cd04cb974ebbd1a5b8411e0fccf7e2228c565356c2766e0da8ea78c68029dee0fa214b5b5bd7f6e1b86b1f396f70bd42f1b6b0a5e856900d6a16682bfaec38544ea365a5f8518054202082dfaee60a5dd165d1d5d0d45fbffd4e9b073bb0055fa306555e894e9499c421a76b71757a364a7333a96462a5c53f60456f67b92309fe1a52dd703052f782d86cd3d6a061ead50136034137e57744be13849e5a677d80b5242df2e25617bae89b6485d3da9a520433c8d5780de18cd5c4a599aa56f4831a7898a2d2830e088478be8518e0a975ba91b4c0ee5000dfb795aef524b70a33970ae5eeb79af193bfaa063d9232ca18458d5a6634a58c9431fbc807a44f56d061c80894874a040ae900a40e18f3fb60126f047594e48156c7349a8424cd39ef814615692f280220dd748da0dfca0848ea5ac5e592c42076529d56a0c6e1b76f87b1de25b83432075947cc621f774ed3f9bcab95a38325e46c17447d98290a6511395911b76a5a9debba8eb2ed27acc8dec4396141ba929bdfa75ec1950f18d5a68c751fc41ca70bb8291c6e89b24f310f11e1ece49bc6629abbe772e36254f8e289c4c15bd051e35118f3e40aa7db495911ccd0f173db89196d7e1d87cef280f6248057d03d0018c99e620c74dfb285fce07cb15f1dd294424324680db5f651f72dba09b652929297744c57d6e36b26a24cc92485f0af39369e35c93866fc697e9d549e5b97f6a6a58dcaf06239a7d5f435b84641fe3940a1eb594d089a3b6e83ceb9c17a3e04bb88b37a79007821519623b0e7b19c5fbc70f09e4e5f23b4718cbe1ca614edc5321f9cad6376fb7ba0e7f4db56ff41e847115e4cecb5eed783f719fdafe950bc008272e1697fa942a6165e6d69f3c5411680190f398076cc4924f3ce4b4e9e8ea5d818cf76fcffaa5716f199b39c6f5ac4951d311b0efb70fb79f364c85fc4d5fd7e2c7cc6bd0584b87d7523fb508534edd36b13065838f256f47dd306dbe0ef3cf220e536398bcf6cea3b8cbc62d8d9587ee21ef5b55950dac856bd9c23393d4904eeb7fee3259cb09b7e9fe2ecbd7d8dc2b5f0977150c71537b6ee05183401add9dce6b9963c2bae5b595c3b712f69e1a0736e04ae72a93eb67b97f2da8a1024bb7450d648dd757838709b9e1babbf01c61cd8fc','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156527,28723,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156545,28724,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156547,28724,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156549,28724,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156567,28725,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156569,28725,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156571,28725,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156589,28727,'5308ddfa-4a5b-4f7b-83ce-9d1b528e050d',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral','Solution',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156591,28727,'f77db491-31c4-4a7c-a114-0f3244c97090',25.0,50.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg','Oral',NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4c060011730396',NULL,NULL),(156593,28727,'1e5004f1-e79e-4e0b-9f3f-25f6bbc15255',1.5,3.0,6,NULL,x'789cb556c972e33610fd953e5a55b2365bb3e4a658f60cabe4a52c3ba91c2112121183040d80b275cb35e77c437e6cbe24af416a21ed2476a672d14202afbb5fbf5ea6d7f3c997739a5c4d6932bd8caea2f9ddede42ebabea24956a85869ad72127942aed40b117b91d1d25852f9af32f6cae494890d2d24892453b9725e5a99d0624352f9545ac207453f91a97f5d9235a597ae4717788417db6b563058379c4a8c93148b9c61576a2d73c673da3cc12a0ee28129dd8107660d43c29396c2791a0ebefdf6c7704cc0654b6c9ab18476860113a901c94e22ae9595021e53a274c9508e9ee0368d03c46040d98ccc9204c5262be0e042cb7054e69e84032b2d8796a5dbf9331c03e364b075a3f79d7426521695b5ac7471a9c5c19d1e1d3929691add9e9f71e6e674717d4bf7f3f363bab1b21015b7c14ed4408876565df5dde9d11d12602502ce649ec0b6484aed3925622503196f0b43391af6c6b4a2a3213e0e2fb9906367125566e404c00b0df606e1f41eeee5b90e7943270c397a1be4f05f0125320569a9674a4d691d475f3b5e9bb2225f311f85950e59af20bcf142b7b8884dee5916c170b0b333bc7df566f2bae1656c2c8c16264f1c7b236a5f80d264b4df660e879b04f51b445429ae62089506c4fd6507227442b9f1249f6309019ca24a44e6a8e03a119b1eddc844096f554c371056606548bf48e809481376d1d2b54e70bcada54428bdd9197d2b19f7f31baed56267b6d89a45ae4eb84a57c1b98715a32e4cb2a127a956a96f16d15a89d7cb15d8f2b1149a5d536b151c858bae56c78786362a7bfd87551f5c6ccbe2557dfc6fe2603e5e11c8a862e230edd5933d50cdd22e939c1f2796d26f02a05c2e552ce2cdbb9d7995e6977dea6fb298222341700b89562f9d170bad5c2a9343a9ed4e87d4aa7c45a78390714b99b172abdb45353dd0b662d093f039ae9dd0c3764a0cedd05555e6bfaf1698c198e511ae1eca8ba79f283687203cfa542ea1b31a6e78ca289056048d806ab0af09e1625675111686599c2a9d58d002e725e6561286d1d69eb1acb3dcab4cc5d62cf81ef2a331293970e079150031e4321659186e874ebe27cb61c69ccdb0219c4d6634bfbb9f46e7f383c11161442a56c0adcc61f5a2ccaba423b67df28203e16056abde86d3cbed69ce07263404550dad0710e655ecfe51938205803b501bc815cb259c9249975299c7324086111828cb39dfe199090bca1300e14426aa3a85fa98a8146bc1ba5e5f9a1e56397f670fab5b982be3744fc65eb28d02d2d2218b162d09a7100e4307310b0e2630c85e950e2d8b0a0b730acfd95ecb994609f095bd345aa5f003dd4d7e9c9d63e2b5969479239ea8298869d5fcbe946899e1fd4d23cd950ca27db2cf588788131938c3aa66433c47d9ac9f71afea7d3cc930b73a072ef4f7e6bf0abd3c9ea9252e7c65f97700bf9f2bffc1eb6fbfff89e56c582f29c761d83fd287143f1fe9538af50dbf469f69dc3a311c613dc43f94eee7d6abd1694a3f4372d018d2e6a4c59a11ef63c6f0106b0c407437d96de5037e66e89574b410dcbcc242f6dcadc758d5a8eaf58befd50aea6c77c592ef20c7902f34eb7106b6d6027b2a17bb397422de125f37ffb693b52677030ded06b21418a9280c2f5f166c8f2e0514bb9db8470fab0e3d63e93b1d1cc3e30e7d1ce1ef0b3317a837be35e87d1ae3bd586065ae3cfe0b70b275c5','dosage_and_administration','DailyMed SPL Enhanced',1,'g','Oral','Injection',NULL,0,NULL,x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2b0100895c0a0a',NULL,NULL),(156610,22203,'875cc32a-219c-4b6b-802a-98a47cbc9a78',NULL,NULL,NULL,NULL,NULL,'indications','DailyMed SPL Enhanced',0,NULL,NULL,NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(156611,22203,'875cc32a-219c-4b6b-802a-98a47cbc9a78',1.5,3.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg',NULL,'Capsule',NULL,0,NULL,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(156612,22203,'875cc32a-219c-4b6b-802a-98a47cbc9a78',0.5,1.0,NULL,NULL,x'789ca58fc14ec24010865fe5bfad2695580b1ebc358270010c8b0fb074877642992dcb42834f6fa160d283d1c4cb24f3e7cb3ff32518ce753a1ee16dbe986aa4b321f472319a8d97138d5753ed0f25ed5ff0d81b609b47889b893b24b8472a26f754b22564572ec2877ebfb2309ea0f993a0fa2a4261bc454ea5092c37be098f2c399a9a135c6576874b158c58d40507ba852b674f11785b799640162aee0f120527dfb86a8f5eb2338d9a43815569b20d5836c89c04c372bed6360707b75e3fb44be56a4bbef7b352dc154a7e11ea3cff57a3e7a7ae51fc6f9f2f0a009e5e','instructions_for_use','DailyMed SPL Enhanced',0,'mg','Oral','Capsule',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(156613,28152,'875cc32a-219c-4b6b-802a-98a47cbc9a78',NULL,NULL,NULL,NULL,NULL,'indications','DailyMed SPL Enhanced',0,NULL,NULL,NULL,NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(156614,28152,'875cc32a-219c-4b6b-802a-98a47cbc9a78',1.5,3.0,12,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',1,'mg',NULL,'Capsule',NULL,0,NULL,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c0b484dc94c2c29ca4cd651f0482d482cc94c56f0cc2d48cc2cca4dcd2b01009ed90ad6',NULL,NULL),(156615,28152,'875cc32a-219c-4b6b-802a-98a47cbc9a78',0.5,1.0,NULL,NULL,x'789ca58fc14ec24010865fe5bfad2695580b1ebc358270010c8b0fb074877642992dcb42834f6fa160d283d1c4cb24f3e7cb3ff32518ce753a1ee16dbe986aa4b321f472319a8d97138d5753ed0f25ed5ff0d81b609b47889b893b24b8472a26f754b22564572ec2877ebfb2309ea0f993a0fa2a4261bc454ea5092c37be098f2c399a9a135c6576874b158c58d40507ba852b674f11785b799640162aee0f120527dfb86a8f5eb2338d9a43815569b20d5836c89c04c372bed6360707b75e3fb44be56a4bbef7b352dc154a7e11ea3cff57a3e7a7ae51fc6f9f2f0a009e5e','instructions_for_use','DailyMed SPL Enhanced',0,'mg','Oral','Capsule',NULL,0,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL),(156617,5345,'1d1d5818-1594-4f54-90a9-ae9a9afcdc67',1.0,1.0,24,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Tablet',NULL,1,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c734f2dca4c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2bd151f0482d482cc94c4612030098b0114f',NULL,NULL),(156620,5345,'03fb3108-1856-466d-bf88-0eac96139551',1.0,1.0,24,NULL,x'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','dosage_and_administration','DailyMed SPL Enhanced',0,'mg','Oral','Tablet',NULL,1,NULL,x'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',x'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',NULL,NULL,NULL,NULL,NULL,NULL,NULL,NULL,x'789c734f2dca4c2c29ca4cd651084acd4bcc51f0cc2d48cc2cca4dcd2bd151f0482d482cc94c4612030098b0114f',NULL,NULL);
